Fakeeh University Hospital introduces epidural stimulation for spinal recovery

UAE—Fakeeh University Hospital (FUH) in the United Arab Emirates has partnered with Verita Neuro to launch the Middle East’s first epidural stimulation program, bringing groundbreaking hope to patients with spinal cord injuries.

This landmark initiative establishes Dubai as a premier destination for cutting-edge neurological recovery, offering innovative treatments previously unavailable in the region.

Dr. Mohaymen Abdelghany, Group CEO and Board Member of Fakeeh Health, as well as CEO of Fakeeh University Hospital, emphasized that this strategic collaboration with Verita Neuro demonstrates their unwavering commitment to delivering world-class, evidence-based medical care throughout the UAE.

The introduction of epidural stimulation at Fakeeh University Hospital means that patients suffering from spinal cord injuries no longer face the burden of traveling abroad to access advanced neurorehabilitation services.

Dr. Abdelghany explained that this partnership with Verita Neuro actively redefines the standard of care across the Middle East by restoring mobility, independence, and hope to those whose lives have been affected by spinal cord injuries.

Through this collaboration, Fakeeh University Hospital continues expanding its portfolio of innovative treatments while solidifying its mission to provide the highest standards of medical care in Dubai and throughout the region.

Julian Andriesz, Chief Executive Officer of Verita Neuro, highlighted that his organization has established itself as a global pioneer in reconnecting brain-body pathways, enabling patients to regain voluntary movement and restore vital autonomic functions.

He expressed his enthusiasm about partnering with Fakeeh University Hospital, which he described as one of the region’s most respected academic medical centers and the ideal collaborator for introducing these cutting-edge therapies to Middle Eastern patients.

Dr. Nasir Majeed, Chief Medical Officer of Verita Neuro, noted that Dubai’s world-class medical infrastructure provides the perfect environment for introducing their proprietary epidural stimulation treatment.

This technology delivers personalized, life-changing neurological restoration directly in the heart of the Middle East, making advanced care accessible to patients throughout the region.

The epidural stimulation procedure involves surgically implanting a specialized neurostimulation device on the posterior structures of the lumbar spinal cord.

This device delivers precisely calibrated electrical currents that effectively bridge nerve signals from the brain to spinal cord tissue located below the injury site.

This innovative “bridging” effect creates the possibility for patients to regain voluntary movement while restoring various involuntary body functions to normal operation.

Medical professionals can implant the epidural stimulation device in patients who have sustained either complete or incomplete spinal cord injuries.

Patients control and program the device using a handheld module that measures no larger than a standard smartphone, offering convenience and independence in managing their treatment.

Verita Neuro’s proprietary protocol aims to restore mobility for individuals living with spinal cord injuries by enabling them to stand independently, take assisted steps, and experience numerous additional improvements.

Patients typically see enhanced bowel and bladder control, reduced spasticity, and restored autonomic functions, dramatically improving their quality of life and daily independence.